Huailong Xu

804 total citations
17 papers, 658 citations indexed

About

Huailong Xu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Huailong Xu has authored 17 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Huailong Xu's work include Glycosylation and Glycoproteins Research (5 papers), Autophagy in Disease and Therapy (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Huailong Xu is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Autophagy in Disease and Therapy (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Huailong Xu collaborates with scholars based in China and Spain. Huailong Xu's co-authors include Jinku Bao, Jiaying Yu, Wenwen Li, Juanjuan Shan, Cheng Qian, Bo Liu, Zhi Yang, Jun Chen, Limei Liu and Junjie Liu and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer Research.

In The Last Decade

Huailong Xu

17 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huailong Xu China 14 398 158 146 134 107 17 658
Ramachandran Rashmi United States 15 717 1.8× 136 0.9× 96 0.7× 129 1.0× 169 1.6× 18 1.0k
Malia B. Potts United States 11 571 1.4× 91 0.6× 130 0.9× 114 0.9× 96 0.9× 18 771
Xisha Chen China 13 544 1.4× 217 1.4× 107 0.7× 123 0.9× 189 1.8× 21 800
Wen-Chi Feng Taiwan 7 371 0.9× 115 0.7× 52 0.4× 127 0.9× 144 1.3× 9 597
Abdelouahid El‐Khattouti France 11 333 0.8× 145 0.9× 83 0.6× 147 1.1× 86 0.8× 14 560
Ki Cheong Park South Korea 16 360 0.9× 190 1.2× 93 0.6× 113 0.8× 114 1.1× 36 666
Jyoti Kanwar India 5 517 1.3× 249 1.6× 75 0.5× 71 0.5× 78 0.7× 25 867
Reyaz ur Rasool India 17 370 0.9× 174 1.1× 64 0.4× 64 0.5× 97 0.9× 26 694
Marta Di Martile Italy 15 455 1.1× 127 0.8× 103 0.7× 64 0.5× 117 1.1× 35 649

Countries citing papers authored by Huailong Xu

Since Specialization
Citations

This map shows the geographic impact of Huailong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huailong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huailong Xu more than expected).

Fields of papers citing papers by Huailong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huailong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huailong Xu. The network helps show where Huailong Xu may publish in the future.

Co-authorship network of co-authors of Huailong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Huailong Xu. A scholar is included among the top collaborators of Huailong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huailong Xu. Huailong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Jun, et al.. (2023). Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors. Cancer Research. 84(1). 84–100. 44 indexed citations
2.
3.
Liu, Yongliang, Guiqin Wang, Jiasi Zhang, et al.. (2021). CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia. Stem Cell Research & Therapy. 12(1). 86–86. 23 indexed citations
4.
Xiang, Junyu, Ni Zhang, Hui Sun, et al.. (2019). Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Gastroenterology. 158(3). 664–678.e24. 83 indexed citations
5.
6.
Wei, Zhihao, Huailong Xu, Juanjuan Shan, et al.. (2019). Sirtuin‐1/Mitochondrial Ribosomal Protein S5 Axis Enhances the Metabolic Flexibility of Liver Cancer Stem Cells. Hepatology. 70(4). 1197–1213. 68 indexed citations
7.
Luo, Yongli, Zhi Yang, Li Su, et al.. (2016). Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma. Cancer Letters. 375(2). 390–399. 38 indexed citations
8.
Xu, Huailong, Zijie Wang, Xiaomeng Liang, et al.. (2014). In silico identification of novel kinase inhibitors targeting wild-type and T315I mutant ABL1 from FDA-approved drugs. Molecular BioSystems. 10(6). 1524–1537. 23 indexed citations
9.
Shi, Zheng, Zijie Wang, Huailong Xu, et al.. (2013). Modeling, docking and dynamics simulations of a non-specific lipid transfer protein from Peganum harmala L.. Computational Biology and Chemistry. 47. 56–65. 12 indexed citations
10.
Li, Xin, et al.. (2013). Autophagy modulation as a target for anticancer drug discovery. Acta Pharmacologica Sinica. 34(5). 612–624. 61 indexed citations
11.
Wang, Nan, Huailong Xu, Xu Zhao, et al.. (2012). Network-Based Identification of Novel Connections Among Apoptotic Signaling Pathways in Cancer. Applied Biochemistry and Biotechnology. 167(3). 621–631. 15 indexed citations
12.
Xu, Huailong, Chunyang Li, Xuemei He, et al.. (2011). Molecular modeling, docking and dynamics simulations of GNA-related lectins for potential prevention of influenza virus (H1N1). Journal of Molecular Modeling. 18(1). 27–37. 12 indexed citations
13.
Li, Wenwen, Jiaying Yu, Huailong Xu, & Jinku Bao. (2011). Concanavalin A: A potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics. Biochemical and Biophysical Research Communications. 414(2). 282–286. 95 indexed citations
14.
Liu, Bo, Jinming Wu, Jing Li, et al.. (2010). Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis and autophagy via blocking Ras–Raf and PI3K–Akt signaling pathways. Biochimie. 92(12). 1934–1938. 50 indexed citations
15.
16.
Li, Chunyang, Huailong Xu, Bo Liu, & Jinku Bao. (2010). Concanavalin A, from an Old Protein to Novel Candidate Anti-Neoplastic Drug. Current Molecular Pharmacology. 3(3). 123–128. 34 indexed citations
17.
Li, Chunyang, Huailong Xu, Bo Liu, & Jinku Bao. (2010). Concanavalin A, from an Old Protein to Novel Candidate Anti-Neoplastic Drug. Current Molecular Pharmacology. 3(3). 123–128. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramachandran Rashmi Breakdown of academic impact, for papers by Malia B. Potts Breakdown of academic impact, for papers by Xisha Chen Breakdown of academic impact, for papers by Wen-Chi Feng Breakdown of academic impact, for papers by Abdelouahid El‐Khattouti Breakdown of academic impact, for papers by Ki Cheong Park Breakdown of academic impact, for papers by Jyoti Kanwar Breakdown of academic impact, for papers by Reyaz ur Rasool Breakdown of academic impact, for papers by Marta Di Martile
Rankless by CCL
2026